← Leaderboards
Michael Rosenzweig
Beckman Research Institute/City Of Hope
$902,308
Attributed
$2,706,923
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $718.9K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,706,923 · 1
By mechanism
R01$2,706,923 · 1
Top collaborators
- Flavia Pichiorri4 shared
- Steven Terry Rosen4 shared
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Sophia S. Wang$9,836,949
- Steven Terry Rosen$39,410,931
- Jeffrey Y Wong$4,970,582
- Enrico Caserta$564,465
- Behnam Badie$11,237,051
Others in their field
Other Emerging Leaders on “African American”
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$16,747,735
- Badri N Vardarajan · University Of Miami School Of Medicine$15,302,586
- Michal Engelman · University Of Wisconsin-Madison$12,644,710
- Virginia Kan · George Washington University$9,272,934
- Nicholas David Thomson · Virginia Commonwealth University$9,136,838
- Jorge Eduardo Chavarro · Harvard School Of Public Health$8,571,098
Research focus
African AmericanAffectAmericanBiologicalBone MarrowBurden Of IllnessCancer CellCell Culture TechniquesCellsC-Myc GenesCohortColorCorrelative StudyCostCustomCyp1a2 GeneCyp2c19 GeneCytometryCytotoxicityDesignDhodh GeneDiagnosticDisease OutcomeDisease Progression
Grant awards (4)
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans$677,645
R01 · FY2025 · CA
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans$653,591
R01 · FY2023 · CA
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans$656,771
R01 · FY2022 · CA
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans$718,916
R01 · FY2021 · CA